HANNAH BANACH: Open Payments
NPI 1255947610 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,848 in 135 payments from 26 companies in 2025. Trend: 2023 $25,377 · 2024 $25,178 · 2025 $25,848
Speaker / faculty: $14,017Travel & lodging: $8,818Food & beverage: $3,014
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 33 | $23,669 |
| ABBVIE INC. | 14 | $266 |
| AstraZeneca Pharmaceuticals LP | 6 | $254 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $235 |
| Vanda Pharmaceuticals Inc. | 8 | $231 |
| PFIZER INC. | 10 | $161 |
| Otsuka America Pharmaceutical, Inc. | 7 | $154 |
| Lilly USA, LLC | 6 | $102 |
| GlaxoSmithKline, LLC. | 6 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $77 |
Products named: Wegovy, CAPLYTA, FANAPT, REXULTI, BREZTRI, NURTEC ODT, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
